BMPR2 mutation and clinical response to imatinib in a case of heritable pulmonary arterial hypertension

BMPR2 mutation and clinical response to imatinib in a case of heritable pulmonary arterial hypertension

Abstract Bone morphogenetic protein receptor 2 (BMPR2) mutation is the most common gene mutation implicated in the pathogenesis of pulmonary arterial hypertension (PAH). We describe, for the first time, an excellent clinical response to tyrosine kinase inhibitor imatinib in a patient with heritable...

Full description

Bibliographic Details
Main Authors: Shine Kumar, Lalitha Biswas, Anju Choorakottayil Pushkaran, Raman Krishna Kumar
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Pulmonary Circulation
Subjects:
Bmpr2 mutation
hereditary
imatinib
pulmonary hypertension
Online Access:https://doi.org/10.1002/pul2.12335

Internet

https://doi.org/10.1002/pul2.12335

Similar Items